Document is current
Any future updates will be listed below
-
Authors
Ou, Feiya https://orcid.org/0000-0001-8289-4025
Liu, Tian-Tian https://orcid.org/0000-0001-9377-9938
Desai, Pritesh https://orcid.org/0000-0002-4697-9475
Ferris, Stephen T.
Kim, Sunkyung
Shen, Haolin https://orcid.org/0000-0003-1550-2831
Ohara, Ray A. https://orcid.org/0000-0001-7897-3169
Jo, Suin https://orcid.org/0000-0002-7575-9017
Chen, Jing
Postoak, J. Luke
Du, Siling
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Murphy, Theresa L.
Murphy, Kenneth M. https://orcid.org/0000-0002-3505-9630
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI150297, R21AI164142, R01AI162643, R21AI163421)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA248919)
Cancer Research Institute
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 9 September 2024
First Online: 7 October 2024
Competing interests
: M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, Moderna, Merck, GlaxoSmithKline, IntegerBio and Akagera Medicines. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, IntegerBio and Emergent BioSolutions. The other authors declare no competing interests.
